Tethys Petroleum Limited Press Release: Olisol Transaction

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tethys Petroleum Limited Press Release: Olisol Transaction Update

GRAND CAYMAN, CAYMAN ISLANDS--(Marketwired - Jan. 22, 2016) -

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO US NEWSWIRE SERVICES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF SUCH JURISDICTIONS. THE OFFERS AND SALES OF SECURITIES REFERRED TO BELOW HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION UNDER THE SECURITIES ACT OR AN EXEMPTION FROM SUCH REGISTRATION.

Tethys Petroleum Limited ("Tethys" or the "Company") (TSX:TPL)(LSE:TPL) today provided an update on the previously announced US$15 million convertible debt facility ("Interim Facility") with Olisol Petroleum Limited ("OPL"), a wholly owned subsidiary of Olisol Investments Limited (together with OPL, "Olisol").

The Interim Facility was entered into with OPL on November 19, 2015, as the first transaction of those contemplated in the Letter of Intent signed with Olisol and announced by Tethys on November 9, 2015 ("LOI"). Under the terms of the Interim Facility, Tethys was entitled to draw down the corresponding funds within two business days of entering into the facility and, as announced on December 29, 2015, the Company submitted draw down notices for the entire loan amount of US$15 million on November 21, 2015.

Despite Olisol having provided written confirmation, in advance of the Company entering into the Interim Facility, of its bank accounts containing funds totaling in excess of US$15 million, no further funds have been received by the Company from Olisol since receipt of the US$5,138,918 in late November as previously announced which was used to repay the US$5 million term loan from Nostrum Oil & Gas PLC.

Olisol has continued to inform the Company that the funds are subject to USD transfer restrictions imposed by the bank authorities in Kazakhstan ("Currency Controls"), which have prevented further transfers within the contractually obligated timeframes. In light of this, and acknowledging the difficult economic and business environment in Kazakhstan as indicated by the changes in the value of the Kazakhstani tenge over the past six months, the Company allowed Olisol time to make alternative arrangements to transfer the balance of the loan to Tethys, or one of its Kazakhstan subsidiaries in-country using funds not restricted by Currency Controls. Over the last two months, Olisol has continually stated that they are working hard on the contemplated transactions and has advised the Company on many occasions over this period that funds would be forthcoming imminently, only for each of their own targets to pass without any transfer being made.

Due to the lack of progress by Olisol with these initiatives, the Company set deadlines, the first of which being January 22, 2016 for the receipt of the next US$2 million. This deadline has now passed and the US$2 million has not been received. Olisol has provided assurances that these funds will be forthcoming early next week.

Tethys has been working tirelessly with Olisol to try to resolve the impediments to completing the transactions agreed between the companies, including proposing receipt of funds from offshore Olisol sources and in-county in Kazakhstani tenge. The Board of Directors of Tethys (the "Board") continues to believe that the transactions with Olisol are in the best interests of Tethys stakeholders and that Olisol is a strong in-country strategic partner. With Olisol's assistance the Company has collected overdue debts which has positively affected the Company's balance sheet in the short term. However, due to transaction completion delays, the Board is obligated to consider alternative funding and investment options for the Company, alongside continued discussions with Olisol. The Company has been engaging in discussions with other parties and is now in active negotiations. Should the overdue funds under the Interim Facility arrive in a timely manner however, Tethys will continue to work with Olisol to close the wider transaction.

In the event that the transactions with Olisol are able to proceed, the Company will mail the management information circular in relation to the placing to shareholders and plans to hold a special meeting to approve the transactions as soon as practicable. Further information on this will be provided in due course as appropriate. There is no certainty that this placing will be completed. Any further delays by Olisol may mean that closing cannot be achieved before the expiry of the existing approval from the Ministry of Energy of Kazakhstan for issuance of new shares by the Company, though an extension of this will be sought.

Current Financial Position

The Company currently does not have sufficient funding to meet its requirements over the next few months and therefore, if the transactions with Olisol do not proceed for any reason, the Company's ability to continue as a going concern will be dependent on the Company being successful in securing alternative funding. There is no certainty that the management will be successful nor have sufficient time to implement any alternative transaction.

About Tethys

Tethys is focused on oil and gas exploration and production activities in Central Asia and the Caspian Region. This highly prolific oil and gas area is rapidly developing and Tethys believes that significant potential exists in both exploration and in discovered deposits.

About Olisol

Olisol and its subsidiaries and affiliates have investments in energy and oil & gas operations in the Russian Federation and Kazakhstan. Olisol is incorporated under the laws of Cyprus and is headquartered in Almaty, Kazakhstan.

Disclaimer

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to Olisol's access to funds, the Interim Facility, the placing to Olisol, potential alternatives to the transactions with Olisol and related transactions. When used in this document, the words "expects," "believes," "anticipates," "plans," "may," "will," "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises or guarantees, and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements including risks and uncertainties with respect to completion of the placing and related transactions and receipt of proceeds, required shareholder approval and required regulatory approvals, use of proceeds, waiver of currency controls and receipt of funds pursuant to the Interim Facility.

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the Listing Rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

CAMARCO (Financial PR) Ginny Pulbrook/ Billy Clegg / Georgia Mann +44 (0) 203 757 4983 info@tethyspetroleum.com www.tethyspetroleum.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 47

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 56

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 101

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 150

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 92

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Growth of the Digital Signage Market Today

Updated Category News Views 84

The digital signage market was transforming fast, with projections showing a jump from USD 20.1 billion in 2024 to around USD 27.3 billion by 2029—talk about a solid compound annual growth rate of 6.3%. Traders were buzzing over the factors driving this upward trend: high-res displays and expanding infrastructure in emerging markets had everyone seeing green. Market...

Continue Reading
Exploring the Potential of Healthcare Stocks Amid Market Growth

Updated Category News Views 189

The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...

Continue Reading
Recognizing Excellence: Nominate for the Paralegal of the Year Award

Updated Category News Views 217

Nominations Now Open for the 2025 AAJ Paralegal of the Year Award The American Association for Justice (AAJ) proudly announces that nominations for the 2025 Paralegal of the Year Award are now open. This award, sponsored by Advocate Capital, Inc., is a wonderful opportunity to acknowledge and applaud the significant contributions of paralegals within our civil justice...

Continue Reading
Mavsign and RouteOne Revolutionize Automotive Deal Processes

Updated Category News Views 174

Mavsign and RouteOne Transforming Automotive Transactions Mavsign, renowned for its expertise in remote document signings and compliance solutions, has announced an exciting partnership with RouteOne, a leader in automotive financing solutions. This collaboration aims to enhance the efficiency and security of automotive transactions by integrating both companies'...

Continue Reading
Revance Stockholders Encouraged to Support Crown's Tender Offer

Updated Category News Views 122

Crown's Tender Offer for Revance Stock: Key Information Revance Therapeutics, Inc. (NASDAQ: RVNC) stockholders are being urged to support Crown Laboratories, Inc. by tendering their shares before the upcoming deadline. This is an important moment as Crown's tender offer presents the only current proposal post Teoxane's withdrawal. Details of the Crown Offer Crown has made...

Continue Reading